Coronavirus Disease 2019 : Clinical Review

INTRODUCTION: In December 2019, an outbreak of pneumonia caused by a novel coronavirus occurred in Wuhan, the capital of Central China's Hubei Province and has been declared a public health emergency of international concern by the World Health Organization since January 2020.

MATERIAL AND METHODS: A comprehensive search using the PubMed database was carried out to summarize the latest published information about the epidemiology, definition, pathogenesis, clinical characteristics, treatment options, prognosis and prevention of coronavirus disease 2019.

DISCUSSION: This new strain of coronavirus, named severe acute respiratory syndrome coronavirus 2, enters human cells that express angiotensin-converting enzyme II receptors, which exist in the respiratory, gastrointestinal and genitourinary tracts and heart, causing coronavirus disease. Transmission occurs essentially through the respiratory tract and the main symptoms are fever, cough and dyspnea. Diagnosis is based on epidemiological, clinical and imaging features and confirmed by nucleic acid testing.

CONCLUSION: Despite intensive research, the exact origin of the virus and pathophysiology of coronavirus disease is not yet completely known, and clinically approved vaccines and drugs that target severe acute respiratory syndrome coronavirus 2 are lacking.

Errataetall:

CommentIn: Acta Med Port. 2020 Oct 08;:. - PMID 33079058

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:33

Enthalten in:

Acta medica portuguesa - 33(2020), 7-8 vom: 01. Juli, Seite 505-511

Sprache:

Englisch

Beteiligte Personen:

Gouveia, Cristina Carvalho [VerfasserIn]
Campos, Luís [VerfasserIn]

Links:

Volltext

Themen:

2494G1JF75
3QKI37EEHE
415SHH325A
4QWG6N8QKH
83905-01-5
886U3H6UFF
Adenosine Monophosphate
Alanine
Amides
Antiviral Agents
Azithromycin
COVID-19
Chloroquine
Coronavirus Infections
EW5GL2X7E0
Favipiravir
Glucocorticoids
Hydroxychloroquine
Journal Article
Lopinavir
OF5P57N2ZX
Pyrazines
Remdesivir
Review
Severe Acute Respiratory Syndrome

Anmerkungen:

Date Completed 18.11.2020

Date Revised 18.02.2021

published: Print-Electronic

CommentIn: Acta Med Port. 2020 Oct 08;:. - PMID 33079058

Citation Status MEDLINE

doi:

10.20344/amp.13957

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310783437